Explanipedia

Accuracy in Diagnosis of Celiac Disease Without Biopsies in Clinical Practice Open

Katharina Werkstetter, Ilma R. Korponay‐Szabó, Alina Popp, Vincenzo Villanacci, Marianna Salemme , et al. · 2017

Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With Thalidomide Open

Marzia Lazzerini, Vincenzo Villanacci, Maria Chiara Pellegrin, Stefano Martelossi, Giuseppe Magazzù , et al. · 2017

Small Bowel Carcinomas in Coeliac or Crohn’s Disease: Clinico-pathological, Molecular, and Prognostic Features. A Study From the Small Bowel Cancer Italian Consortium Open

Alessandro Vanoli, Antonio Di Sabatino, Daniela Furlan, Catherine Klersy, Federica Grillo , et al. · 2017

In comparison with CrD-SBC, CD-SBC patients harbour MSI and high TILs more frequently and show better outcome. This seems mainly due to their higher TIL density, which at multivariable analysis showed an independent prognostic value. MSI/T…

Persistent Intraepithelial Lymphocytosis in Celiac Patients Adhering to Gluten-Free Diet Is Not Abolished Despite a Gluten Contamination Elimination Diet Open

Bárbara Zanini, Monica Marullo, Vincenzo Villanacci, Marianna Salemme, Francesco Lanzarotto , et al. · 2016

The gluten-free diet (GFD) is the only validated treatment for celiac disease (CD), but despite strict adherence, complete mucosal recovery is rarely obtained. The aim of our study was to assess whether complete restitutio ad integrum coul…

hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance Open

Elena Lastraioli, Tiziano Lottini, Jessica Iorio, Giancarlo Freschi, Marilena Fazi , et al. · 2016

Barrett's esophagus (BE) is the only well-known precursor lesion of esophageal adenocarcinoma (EA). The exact estimates of the annual progression rate from BE to EA vary from 0.07% to 3.6%. The identification of BE patients at higher risk …

Shedding light on the dark side of microscopic colitis Open

Vincenzo Villanacci, E. Antonelli, Marianna Salemme, Gabrio Bassotti · 2016

Letter: histological assessment of disease activity in ulcerative colitis – the problem of score evaluation and validation Open

Vincenzo Villanacci, Marianna Salemme, Gabrio Bassotti, E. Antonelli · 2016

We read with interest the excellent review of Marchal Bressenot et al.1 on the histological assessment of disease activity in ulcerative colitis (UC), and would like to express our appreciation for the accurate analysis of the data, focuse…

The importance of a second opinion in the diagnosis of Barretts esophagus: a real life study Open

Vincenzo Villanacci, Marianna Salemme, Italo Stroppa, Valerio Balassone, Gabrio Bassotti · 2016

The pathological diagnosis of Barrett's esophagus, especially with regard to the presence of dysplasia, is still misinterpreted, particularly in the setting of general Pathology units. Thus, a second opinion from an experienced pathologist…

Adenomyomatosis of the gallbladder in childhood: A systematic review of the literature and an additional case report Open

Filippo Parolini, Giuseppe Indolfi, Miguel Garcia Magne, Marianna Salemme, Maurizio Cheli , et al. · 2016

Considering the remote but possible degeneration leading to cancer and the feasibility of laparoscopic cholecystectomy even in small children, evidence suggests that elective laparoscopic cholecystectomy represent the treatment of choice. …

Fulminant ulcerative colitis in a healthy pregnant woman Open

Rossana Orabona, A. Valcamonico, Marianna Salemme, Stefania Manenti, Guido AM Tiberio , et al. · 2015

This case report concerns a 25-year-old patient with 6-7 bloody stools/d, abdominal pain, tachycardia, and weight loss occurring during the third trimester of pregnancy. Severe ulcerative colitis complicated by toxic megacolon and gravidic…

P260. Virtual chromoendoscopy with FICE is superior to standard colonoscopic surveillaillance for flat visibile dysplasic lesions and raised lesions (polyps and pseudopolyps) evaluation in long-standing ulcerative colitis: a prospective, randomized, trial. Open

B. Huggett, S. Chadokufa, S Sider, T Sawney, Neil Shah , et al. · 2015

Background: ImproveCareNow (ICN) a QI program benchmarking patient visit outcomes against currently 66 pIBD centres, monitoring 18 000 pIBD patients in a live database.Agreed outcomes include Clinical Remission, Steroid-free remission, Nut…

P147. Usefulness of fecal S100A12 in defining mucosal healing in Ulcerative Colitis Open

Taku Kobayashi, Osamu Takeuchi, Satoshi Kuronuma, M Nakano, S Umeda , et al. · 2015

specificity of 89.29%, PPV 89.66% and NPV 86.21% in detecting DL.DSC had a sensitivity of 66.67%, specificity of 88.57%, PPV 50%, NPV 93.94% and EVC had a sensitivity of 100%, specificity of 83.3%, PPV 64.71% and NPV 100%.Conclusions: DL a…

DOP072. Differentiating neoplastic and non neoplastic raised lesions (polyps and pseudopolyps) in long-standing ulcerative colitis: Results from a prospective systematic study using virtual chromoendoscopy with FICE and the Kudo classification. Open

A. Cassinotti, Federico Buffoli, Paolo Fociani, Vincenzo Villanacci, Teresa Staiano , et al. · 2015

DOP071. Endoscopic detection of small bowel adenocarcinoma and dysplasia in patients with jejuno-ileal Crohn's disease: prospective study in a cohort of high risk patients (DYDJI Study) Open

Federico Argüelles‐Arias, Antonio López–Sanromán, Xavier Calvet, Oscar Rincón, Cristina Romero , et al. · 2015

Background: The PODIUM study (Dignass2009) and MOTUS study (Flourié,B.2011)proved the benefit of once daily (qd) mesalazine dosing vs twice daily (bd) dosing.Yet, the effect of real world dosing regimens on adherence and persistence is vit…

Marianna Salemme YOU? Author Swipe